KRISTIAN OENBRINK: Open Payments
NPI 1790364081 · LYNN HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 56 payments from 14 companies in 2025. Trend: 2023 $302 · 2024 $757 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 32 | $430 |
| PFIZER INC. | 3 | $143 |
| ABBVIE INC. | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Corium, LLC | 2 | $54 |
| SHIELD THERAPEUTICS INC | 2 | $43 |
| Amgen Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: Ozempic, NURTEC ODT, QULIPTA, Azstarys, AIRSUPRA, REXULTI, ACCRUFER, EVENITY.
Industry payments across FL — which companies pay providers there.
